Mandatory screening and treatment of immigrants for latent tuberculosis in the USA: Just restraint?

Lancet Infectious Diseases

Volumn 1, Issue 4, 2001, Pages 270-276

  Coker, Richard ^a   Van Weezenbeek, Kitty Lambregts ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST; ECONOMICS; HEALTH; HUMAN; INTERNATIONAL COOPERATION; MASS SCREENING; MIGRATION; PREVALENCE; PUBLIC HEALTH; PUBLIC HEALTH SERVICE; RISK ASSESSMENT; TUBERCULOSIS; UNITED STATES;

CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); COSTS AND COST ANALYSIS; EMIGRATION AND IMMIGRATION; HUMANS; INTERNATIONAL COOPERATION; MASS SCREENING; PREVALENCE; PUBLIC HEALTH; RISK ASSESSMENT; TUBERCULOSIS; UNITED STATES; WORLD HEALTH;

EID: 0035522833     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(01)00122-0     Document Type: Note

References (48)

1. Dowdle W.R. Strategic plan for the elimination of tuberculosis in the United States. MMWR Morb Mortal Wkly Rep. 38:(suppl 3):1989;1-25.
2. Institute of Medicine (US). Ending neglect: the elimination of tuberculosis in the United States. Washington: National Academy Press; 2000.
3. Coker R.J. From chaos to coercion: detention and the control of tuberculosis. 2000;St Martin's Press, New York.
4. Gasner M.R., Maw K.L., Feldman G.E., Fujiwara P.I., Frieden T.R. The use of legal action in New York City to ensure treatment of tuberculosis. N Engl J Med. 340:1999;359-366.
5. Coker R.J. Civil liberties and public good: detention of tuberculous patients and the Public Health Act 1984. Med Hist. 45:2001;341-358.
6. Communicable Diseases Control Act: Norway, 1994.
7. Rose A.M., Watson J.M., Graham C., et al. Tuberculosis at the end of the 20th century in England and Wales: results of a national survey in 1998. Thorax. 56:2001;173-179.
8. http://www.ceses.org/eurotb_eng.htm , accessed 3 Oct 2001.
9. Gostin L.O. Public health law: power, duty, restraint. 2000;University of California Press, Berkeley.
10. McKenna M.T., McCray E., Onorato I. The epidemiology of tuberculosis among foreign-born persons in the United States, 1986 to 1993. N Engl J Med. 332:1995;1071-1076.
11. Ferebee S.H. Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibl Tuberc. 26:1970;28-106.
12. Nolan C.M., Elarth A.M. Tuberculosis in a cohort of Southeast Asian refugees. Am Rev Respir Dis. 137:1988;805-809.
13. Hart P.D., Sutherland I. BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Final report to the Medical Research Council. BMJ. 2:1977;293-295.
14. Comstock G.W., Livesay V.T., Woolpert S.F. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol. 99:1974;131-138.
15. Rieder H.L. Epidemiologic basis of tuberculosis control. 1st ed. 1999;IUATLD, Paris.
16. Menzies D. Tuberculosis crosses borders. Int J Tuberc Lung Dis. 4:2000;153-159.
17. Rivest P., Tannenhaum T., Bedard L. Epidemiology of tuberculosis in Montreal. CMAJ. 158:1998;605-609.
18. Long R., Njoo H., Hershfield E. Tuberculosis 3: epidemiology of the disease in Canada. CMAJ. 160:1999;1185-1190.
19. MacIntyre C.R., Dwyer B., Streeton J.A. The epidemiology of tuberculosis in Victoria. Med J Aust. 159:1993;672-677.
20. Wilcke J.T.R., Poulsen S., Askgaard D.S., Enevoldsen H.K., Ronne T., Kok-Jensen A. Tuberculosis in a cohort of Vietnamese refugees after arrival in Denmark, 1979-1982. Int J Tuberc Lung Dis. 2:1998;219-224.
21. Wang J.-S., Allen E.N., Enarson D.A., Grzybowski S. Tuberculosis in recent Asian immigrants to British Columbia, Canada: 1982-1985. Tubercle. 72:1991;277-283.
22. Schwartzman K., Menzies D. Tuberculosis screening of immigrants to low-prevalence countries. A cost-effectiveness analysis. Am J Respir Rev Crit Care Med. 161:2000;780-789.
23. Anon. Recommendations for prevention and control of tuberculosis among foreign-born persons. Report of the working group on tuberculosis among foreign-born persons. MMWR Morb Mortal Wkly Rep. 47:1998;1-29.
24. Lillebaek T., Andersen A.B., Bauer J., et al. Risk of Mycobacterium tuberculosis transmission in a low-incidence country due to immigration from high-incidence areas. J Clin Microbiol. 39:2001;855-861.
25. Chin D.P., DeRiemer K., Small P.M., et al. Differences in contributing factors to tuberculosis incidence in US-born and foreign-born persons. Am J Respir Crit Care Med. 158:1998;1797-1803.
26. Ball C.A., Barnes M. Public health and individual rights: tuberculosis control and detention procedures in New York City. Yale Law Pol Rev. 12:1994;38-67.
27. Menzies R., Vissandjee B., Amyot D. Factors associated with tuberculin reactivity among the foreign-born in Montreal. Am Rev Respir Dis. 146:1992;752-756.
28. Menzies R., Vissandjee B. Bacille Calmette-Guerin vaccination on tuberculin reactivity. Am Rev Respir Dis. 145:1992;621-625.
29. Wells C.D., Zuber P.L.F., Nolan C.M., Binkin N.J., Goldberg S.V. Tuberculosis prevention among foreign-born persons in Seattle-King County, Washington. Am J Respir Rev Crit Care Med. 156:1997;573-577.
30. Snider D.E. Jr. Bacille Calmette-Guerin vaccinations and tuberculin skin tests. JAMA. 253:1985;3438-3439.
31. Anon. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. MMWR Morb Mortal Wkly Rep 1996; 45 (No RR-4).
32. Geiseler P.J., Nelson K.E., Crispen R.G. Tuberculosis in physicians: compliance with preventive measures. Am Rev Respir Dis. 135:1987;3-9.
33. Greenberg P.D., Lax K.G., Schechter C.B. A decision analysis comparing the tuberculin screening strategy with the BCG vaccination. Am Rev Respir Dis. 143:1991;490-495.
34. Anon. Update. Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations-United States, 2001. MMWR Morb Mortal Wkly Rep. 50:2001;733-735.
35. Talbot E.A., Moore M., McCray E., Binkin N.J. Tuberculosis among foreign-born persons in the United States, 1993-1998. JAMA. 284:2000;2894-2900.
36. Moore M., Onorato I.M., McCray E., Castro K.G. Trends in drug-resistant tuberculosis in the United states, 1993-1996. JAMA. 278:1997;833-837.
37. Binkin N.J., Zuber P.L.F., Wells C.D., Tipple M.A., Castro K.G. Overseas screening for tuberculosis in immigrants and refugees to the United States: current status. Clin Infect Dis. 23:1996;1226-1232.
38. Anon. Tuberculosis among foreign-born persons who had recently arrived in the United States - Hawaii, 1992-1993, and Los Angeles County, 1993. MMWR Morb Mortal Wkly Rep. 44:1995;703-707.
39. Orr P.H., Manfreda J., Hershfield E.S. Tuberculosis surveillance in imigrants to Manitoba. Can Med Assoc J. 142:1990;453-458.
40. Dasgupta K., Schwartzman K., Marchand R., Tannenhaum T., Brassard P., Menzies D. Comparison of cost effectiveness of tuberculosis screening of close contacts and foreign-born populations. Am J Respir Rev Crit Care Med. 162:2000;2079-2086.
41. Grzybowski S., McKinnon N.E., Tuters L., Pinkus G., Philipps R. Reactivations in inactive pulmonary tuberculosis. Am Rev Respir Dis. 93:1966;352-360.
42. Bloch A.B., Cauthen G.M., Simone P.M., Kelly G.D., Dansbury K.G., Castro K.G. Completion of tuberculosis therapy for patients reported in the United States in 1993. Int J Tuberc Lung Dis. 3:1999;273-280.
43. Tan L., Altman R.D., Nielsen N.H. Screening nonimmigrant visitors to the United States for tuberculosis. Arch Intern Med. 161:2001;334-340.
44. Asch S., Leake B., Anderson R., Gelberg L. Why do symptomatic patients delay obtaining care for tuberculosis? Am J Respir Crit Care Med. 157:1998;1244-1248.
45. http://www.ins.usdoj.gov/graphics/aboutins/statistics/illegalalien/index. htm , accessed 3 Oct 2001.
46. Ciesielski S., Esposito D., Protiva J., Piehl M. The incidence of tuberculosis among North Carolina migrant farmworkers, 1991. Am J Public Health. 84:1994;1836-1838.
47. Baradat, Discussion and report, number 5 order of the day at the session of the Grand Committee. 7th International Congress on Tuberculosis; 1908 September 23rd-26th; Washington, DC.
48. Gostin L., Mann J.M. Towards the development of a human rights impact assessment for the formulation and evaluation of public health policies. Health Human Rights. 1:1994;58-80.